Residence Time Evaluation of Marketed OTC Ophthalmic Products
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 25
- Registration Number
- NCT00804791
Circadian Ocular Perfusion Pressure and Ocular Blood Flow
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-12-02
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 35
- Registration Number
- NCT00800540
- Locations
- 🇺🇸
Contact Alcon Call Center at 1-888-451-3937 For Trial Locations, Fort Worth, Texas, United States
Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2012-11-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 26
- Registration Number
- NCT00799422
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2012-06-01
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 236
- Registration Number
- NCT00798759
Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2010-03-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT00798577
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2010-03-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 132
- Registration Number
- NCT00794144
- Locations
- 🇺🇸
Niran Amar, M.D., Waco, Texas, United States
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2018-02-08
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1260
- Registration Number
- NCT00789555
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 197
- Registration Number
- NCT00788541
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2012-10-26
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 263
- Registration Number
- NCT00782717
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 102
- Registration Number
- NCT00772304
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath